Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Clinical trial NCT00841672 · COMPLETED

Trial details

NCT number: NCT00841672
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Hypertension

Start date: 2009-01-01
Primary completion: 2009-09-01
Enrollment: 485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.